ID   EREB2-5
AC   CVCL_W845
SY   EREB2.5; ER/EB2-5
DR   DSMZ; ACC-914
DR   DSMZCellDive; ACC-914
DR   Wikidata; Q54832424
RX   PubMed=7828599;
CC   Doubling time: ~24-48 hours (DSMZ=ACC-914).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 9,12,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,21
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 9,13
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 9
//
RX   PubMed=7828599; DOI=10.1002/j.1460-2075.1995.tb06978.x;
RA   Kempkes B., Spitkovsky D., Jansen-Durr P., Ellwart J.W., Kremmer E.,
RA   Delecluse H.-J., Rottenberger C., Bornkamm G.-W., Hammerschmidt W.;
RT   "B-cell proliferation and induction of early G1-regulating proteins by
RT   Epstein-Barr virus mutants conditional for EBNA2.";
RL   EMBO J. 14:88-96(1995).
//